perfluorooctane sulfonic acid has been researched along with mifepristone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buoso, E; Corsini, E; Galbiati, V; Iulini, M; Linciano, P; Maddalon, A; Marinovich, M; Masi, M; Racchi, M | 1 |
1 other study(ies) available for perfluorooctane sulfonic acid and mifepristone
| Article | Year |
|---|---|
Effects of endocrine disrupting chemicals on the expression of RACK1 and LPS-induced THP-1 cell activation.
Topics: Alkanesulfonic Acids; Androgens; Endocrine Disruptors; Estrogens; Fluorocarbons; Glucocorticoids; GTP-Binding Proteins; Humans; Interleukin-8; Ligands; Lipopolysaccharides; Mifepristone; Molecular Docking Simulation; Neoplasm Proteins; Receptors for Activated C Kinase; Receptors, Androgen; Receptors, Estrogen; RNA, Messenger; THP-1 Cells; Tumor Necrosis Factor-alpha | 2022 |